Feeley Kevin 4
4 · GeneDx Holdings Corp. · Filed Jun 18, 2026
Research Summary
AI-generated summary of this filing
GeneDx (WGS) CFO Kevin Feeley Sells Shares to Cover Taxes
What Happened
Kevin Feeley, Chief Financial Officer of GeneDx Holdings Corp. (WGS), had 7,197 restricted stock units (RSUs) settle into shares (no cash cost) on June 16, 2026. To satisfy tax withholding obligations tied to that settlement, he sold 3,729 shares in multiple open-market transactions on the same date for total proceeds of approximately $226,597. The RSU settlement/derivative conversion is reported at $0 per share.
Key Details
- Transaction date: June 16, 2026; Form 4 filed June 18, 2026.
- Sales: 760 shares @ $59.75 (proceeds $45,413); 2,106 shares @ $60.83 (proceeds $128,106); 863 shares @ $61.50 (proceeds $53,078). Total proceeds ≈ $226,597.
- RSU settlement: 7,197 RSUs converted to shares at $0 (no cash exercise cost). The filing also reports a derivative disposition related to the settlement.
- Shares owned after transaction: 39,954 shares of Class A common stock beneficially owned, plus RSUs representing rights to up to 82,043 additional shares and options to purchase up to 25,906 shares (per filing).
- Footnotes: Sales were a “sell-to-cover” to satisfy tax withholding (non-discretionary). Reported prices for the sale blocks are weighted averages with price ranges provided in the filing.
- Timeliness: Transaction dated 6/16 and Form 4 filed 6/18 — filed within the typical two-business-day window.
Context
This was a routine RSU settlement and sell-to-cover for tax withholding rather than an opportunistic open-market sale or a voluntary disposition. The RSUs settled without cash outlay (reported at $0), and a portion of the resulting shares were sold to meet tax obligations. Such sell-to-cover transactions are common and do not necessarily signal a change in insider sentiment.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
[F1]2026-06-16+7,197→ 43,683 total - Sale
Class A Common Stock
[F2][F3]2026-06-16$59.75/sh−760$45,413→ 42,923 total - Sale
Class A Common Stock
[F2][F4]2026-06-16$60.83/sh−2,106$128,106→ 40,817 total - Sale
Class A Common Stock
[F2][F5][F6]2026-06-16$61.50/sh−863$53,078→ 39,954 total - Exercise/Conversion
Restricted Stock Unit
[F1][F7]2026-06-16−7,197→ 21,590 total→ Class A Common Stock (7,197 underlying)
Footnotes (7)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.26 to $60.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.35 per share, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.69 per share, inclusive.
- [F6]Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 39,954 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 82,043 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
- [F7]6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.